Showing results (41-50 of 133) with videos related to

Sort By:
Pageof 14
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 6, 2009
An ATP-sensitive potassium channel blocker suppresses sodium-induced hypertension through increased secretion of urinary kallikreinYuji Kamata, Tomoe Fujita, Tetsuki Kato, et al.
Shock (Augusta, Ga.)|November 16, 2007
Leukotriene B4/leukotriene B4 receptor pathway is involved in hepatic microcirculatory dysfunction elicited by endotoxinSohei Ito, Yoshiya Ito, Hiroyuki Katagiri, et al.
Journal of Cellular and Molecular Medicine|September 2, 2020
Inhibition of receptor activity-modifying protein 1 suppresses the development of endometriosis and the formation of blood and lymphatic vesselsMasako Honda, Yoshiya Ito, Kyoko Hattori, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 18, 2003
COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivoSatoko Yoshida, Hideki Amano, Izumi Hayashi, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 20, 2007
Gastric mucosal protection against ethanol by EP2 and EP4 signaling through the inhibition of leukotriene C4 productionYouichiro Hattori, Takashi Ohno, Takako Ae, et al.
The Journal of Surgical Research|October 29, 2017
RAMP1 signaling improves lymphedema and promotes lymphangiogenesis in miceToshiaki Mishima, Yoshiya Ito, Nobuyuki Nishizawa, et al.
International Journal of Experimental Pathology|October 16, 2021
The role of thromboxane prostanoid receptor signaling in gastric ulcer healingSakiko Yamane, Hideki Amano, Yoshiya Ito, et al.
Japanese Journal of Pharmacology|October 25, 2002
Suppression of dextran sulfate sodium-induced colitis in kininogen-deficient rats and non-peptide B2 receptor antagonist-treated ratsKazuhisa Kamat, Izumi Hayashi, Yoshito Mizuguchi, et al.
British Journal of Clinical Pharmacology|September 19, 2002
Pharmacokinetics and pharmacodynamics of TF-505, a novel nonsteroidal 5alpha-reductase inhibitor, in normal subjects treated with single or multiple dosesTomoe Fujita, Yoshiaki Matsumoto, Toshimi Kimura, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 26, 2009
Reduced angiogenesis and delay in wound healing in angiotensin II type 1a receptor-deficient miceMaya Kurosaka, Tatsunori Suzuki, Kanako Hosono, et al.
Pageof 14